One of the top ranked lncRNAs, SNHG15, has not been experimentally linked to blood cancer; however, its regulation of the ubiquitin-proteasome system and its established oncogenic role in osteosarcoma suggest it may be a promising lncRNA for blood cancers (Ireland, 1986; Jiang et al., 2018). Here, SNHG15 is linked to hematopoietic and lymphoid system neoplasm.